Ascentage Pharma Group International
Ascentage Pharma Group International (AAPGV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AAPGV · as of Jun 8, 2026
Key Statistics
Explore Ascentage Pharma Group International Data
aapgv stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
aapgv competitorsAAPGV
ATYR
BCYP
CYT
DBTX
GRAYStock Performance
Full HistoryAbout Ascentage Pharma Group International
Ascentage Pharma Group International a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's…
what is ascentage pharma group international · aapgv stock overview · ascentage pharma group international company profile · who is ascentage pharma group international ceo · aapgv OTC · ascentage pharma group international headquarters · ascentage pharma group international business segments
About Stock Overview & Key Data
Ascentage Pharma Group International (AAPGV) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 24, 2025. As of the latest trading session, AAPGV stock price is $17.38, with a market capitalization of $127.3M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2024, Ascentage Pharma Group International reported revenue of $980.6M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ascentage Pharma Group International (AAPGV) stock price is $17.38. The stock is traded on OTC under the ticker symbol AAPGV. The 52-week range is $16.50 – $18.00.